(Q38087982)

28 August 2017

title

Biomarkers for early detection of ovarian cancer (English)

1 reference

28 August 2017

0 references

1 reference

Long Nguyen

1

1 reference

28 August 2017

Segundo Joel Cardenas-Goicoechea

2

1 reference

28 August 2017

Pierre Gordon

3

1 reference

28 August 2017

Christina Curtin

4

1 reference

28 August 2017

Mazdak Momeni

5

1 reference

28 August 2017

Linus Chuang

6

1 reference

28 August 2017

David Fishman

7

1 reference

28 August 2017

publication date

1 March 2013

1 reference

28 August 2017

1 reference

28 August 2017

volume

9

1 reference

28 August 2017

issue

2

1 reference

28 August 2017

page(s)

171-85; quiz 186-7

1 reference

Recent progress in the diagnosis and treatment of ovarian cancer

28 August 2017

cites work

1 reference

21 January 2018

Global cancer statistics

1 reference

Clinical practice. Screening for ovarian cancer

21 January 2018

1 reference

Effect of Screening on Ovarian Cancer Mortality

21 January 2018

1 reference

The UKCTOCS experience--reasons for hope?

21 January 2018

1 reference

Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS).

21 January 2018

1 reference

Committee Opinion No. 477: the role of the obstetrician-gynecologist in the early detection of epithelial ovarian cancer

21 January 2018

1 reference

SGO White Paper on ovarian cancer: etiology, screening and surveillance

21 January 2018

1 reference

Genetic counseling and testing for common hereditary breast cancer syndromes: a paper from the 2007 William Beaumont hospital symposium on molecular pathology

21 January 2018

1 reference

Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies

21 January 2018

1 reference

Intercepting pelvic cancer in the distal fallopian tube: theories and realities

21 January 2018

1 reference

Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: Evidence for a causal relationship.

21 January 2018

1 reference

Diagnosis of serous tubal intraepithelial carcinoma based on morphologic and immunohistochemical features: a reproducibility study

21 January 2018

1 reference

Predictive value of symptoms for early detection of ovarian cancer

21 January 2018

1 reference

Predictors of comprehensive surgical treatment in patients with ovarian cancer.

21 January 2018

1 reference

The role of ultrasound evaluation in the detection of early-stage epithelial ovarian cancer

21 January 2018

1 reference

Long-term survival of women with epithelial ovarian cancer detected by ultrasonographic screening.

21 January 2018

1 reference

Contrast-enhanced sonography helps in discrimination of benign from malignant adnexal masses.

21 January 2018

1 reference

Diagnostic parameters to differentiate benign from malignant ovarian masses with contrast-enhanced transvaginal sonography

21 January 2018

1 reference

A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer

21 January 2018

1 reference

Large prospective study of ovarian cancer screening in high-risk women: CA125 cut-point defined by menopausal status

21 January 2018

1 reference

Human epididymis protein 4 (HE4) is a secreted glycoprotein that is overexpressed by serous and endometrioid ovarian carcinomas

21 January 2018

1 reference

Risk of malignancy index in the preoperative evaluation of pelvic masses

21 January 2018

1 reference

Comprehensive analysis of HE4 expression in normal and malignant human tissues

21 January 2018

1 reference

Selection of potential markers for epithelial ovarian cancer with gene expression arrays and recursive descent partition analysis

21 January 2018

1 reference

The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass.

21 January 2018

1 reference

Evaluation of the diagnostic accuracy of the risk of ovarian malignancy algorithm in women with a pelvic mass

21 January 2018

1 reference

Serum HE4 concentration differentiates malignant ovarian tumours from ovarian endometriotic cysts

21 January 2018

1 reference

Diagnostic value of serum human epididymis protein 4 (HE4) in ovarian carcinoma: a systematic review and meta-analysis

21 January 2018

1 reference

A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass

21 January 2018

1 reference

No benefit from combining HE4 and CA125 as ovarian tumor markers in a clinical setting.

21 January 2018

1 reference

Serum HE4 levels are less frequently elevated than CA125 in women with benign gynecologic disorders

21 January 2018

1 reference

Combining CA 125 and SMR serum markers for diagnosis and early detection of ovarian carcinoma

21 January 2018

1 reference

Urinary mesothelin provides greater sensitivity for early stage ovarian cancer than serum mesothelin, urinary hCG free beta subunit and urinary hCG beta core fragment

21 January 2018

1 reference

Characterization of the microheterogeneity of transthyretin in plasma and urine using SELDI-TOF-MS immunoassay

21 January 2018

1 reference

Validation of serum biomarkers for detection of early-stage ovarian cancer.

21 January 2018

1 reference

Serum lipids concentration in women with benign and malignant ovarian tumours.

21 January 2018

1 reference

Apolipoprotein A-I (apoA-I) and apoA-I mimetic peptides inhibit tumor development in a mouse model of ovarian cancer

21 January 2018

1 reference

Development of multiplexed bead-based immunoassays for the detection of early stage ovarian cancer using a combination of serum biomarkers

21 January 2018

1 reference

Vascular cell adhesion molecule-1 is a regulator of ovarian cancer peritoneal metastasis

21 January 2018

1 reference

Development of a multimarker assay for early detection of ovarian cancer

21 January 2018

1 reference

Prognostic significance of interleukin 6 serum levels in patients with ovarian cancer

21 January 2018

1 reference

Circulating IL-8 and anti-IL-8 autoantibody in patients with ovarian cancer

21 January 2018

1 reference

Phase II biomarker trial of a multimarker diagnostic for ovarian cancer

21 January 2018

1 reference

B7-H4 overexpression in ovarian tumors

21 January 2018

1 reference

Expression of serum amyloid a in human ovarian epithelial tumors: implication for a role in ovarian tumorigenesis

21 January 2018

1 reference

Proteomic tracking of serum protein isoforms as screening biomarkers of ovarian cancer.

21 January 2018

1 reference

Novel aspects of oxidative stress-associated carcinogenesis

21 January 2018

1 reference

Increased apoptosis in cancer cells in vitro and in vivo by ceramides in transferrin-modified liposomes

21 January 2018

1 reference

Osteopontin as a potential diagnostic biomarker for ovarian cancer

21 January 2018

1 reference

Serum protein markers for early detection of ovarian cancer

21 January 2018

1 reference

Proteomic-based discovery and characterization of glycosylated eosinophil-derived neurotoxin and COOH-terminal osteopontin fragments for ovarian cancer in urine

21 January 2018

1 reference

The emerging roles of human tissue kallikreins in cancer

21 January 2018

1 reference

Potential markers that complement expression of CA125 in epithelial ovarian cancer

21 January 2018

1 reference

Genomic and proteomic biomarkers for cancer: a multitude of opportunities.

21 January 2018

1 reference

Evaluation of midkine and anterior gradient 2 in a multimarker panel for the detection of ovarian cancer.

21 January 2018

1 reference

Inhibin as a diagnostic marker for ovarian cancer

21 January 2018

1 reference

Detection of M2 macrophages and colony-stimulating factor 1 expression in serous and mucinous ovarian epithelial tumors.

21 January 2018

1 reference

Regulation of colony stimulating factor-1 expression and ovarian cancer cell behavior in vitro by miR-128 and miR-152

21 January 2018

1 reference

Urokinase-type plasminogen activator receptor: a beacon of malignancy?

21 January 2018

1 reference

Targeting the EGF receptor for ovarian cancer therapy

21 January 2018

1 reference

Targeting the epidermal growth factor receptor in epithelial ovarian cancer: current knowledge and future challenges.

21 January 2018

1 reference

The initial steps of ovarian cancer cell metastasis are mediated by MMP-2 cleavage of vitronectin and fibronectin.

21 January 2018

1 reference

Expression of membrane type 1 matrix metalloproteinase (MMP-14) in epithelial ovarian cancer: high level expression in clear cell carcinoma

21 January 2018

1 reference

The context and potential of epigenetics in oncology

21 January 2018

1 reference

Epigenomics of ovarian cancer and its chemoprevention

21 January 2018

1 reference

Molecular profiling uncovers a p53-associated role for microRNA-31 in inhibiting the proliferation of serous ovarian carcinomas and other cancers

21 January 2018

1 reference

MicroRNA signatures in human ovarian cancer

21 January 2018

1 reference

Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer

21 January 2018

1 reference

MicroRNAs: novel biomarkers for human cancer

21 January 2018

1 reference

Disruption of CTCF at the miR-125b1 locus in gynecological cancers

21 January 2018

1 reference

Integrated genomic analyses of ovarian carcinoma

21 January 2018

1 reference

The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform

21 January 2018

1 reference

Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases

21 January 2018

1 reference

microRNA and the pathogenesis of ovarian cancer--a new horizon for molecular diagnostics and treatment?

21 January 2018

1 reference

Use of SELDI-TOF mass spectrometry for identification of new biomarkers: potential and limitations

21 January 2018

1 reference

Quantitative proteome analysis of ovarian cancer tissues using a iTRAQ approach

21 January 2018

1 reference

Microarray-based gene expression studies in ovarian cancer

21 January 2018

1 reference

Overexpression of kallikrein 10 in epithelial ovarian carcinomas

21 January 2018

1 reference

Microvesicles: mediators of extracellular communication during cancer progression

21 January 2018

1 reference

Exosomal miRNAs: Biological Properties and Therapeutic Potential

21 January 2018

1 reference

Nanoparticle analysis of circulating cell-derived vesicles in ovarian cancer patients.

21 January 2018

1 reference

MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer

21 January 2018

1 reference

Combining multiple serum tumor markers improves detection of stage I epithelial ovarian cancer

21 January 2018

1 reference

Assessing lead time of selected ovarian cancer biomarkers: a nested case-control study

21 January 2018

1 reference

A recipe for proteomics diagnostic test development: the OVA1 test, from biomarker discovery to FDA clearance

21 January 2018

1 reference

Performance of the American College of Obstetricians and Gynecologists' ovarian tumor referral guidelines with a multivariate index assay.

21 January 2018

1 reference

Breastfeeding and risk of ovarian cancer in two prospective cohorts

21 January 2018

1 reference

B7-H4 Is a Novel Membrane-Bound Protein and a Candidate Serum and Tissue Biomarker for Ovarian Cancer

21 January 2018

1 reference

Plasma Prealbumin in Women with Epithelial Ovarian Carcinoma

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.2217/WHE.13.2

1 reference

28 August 2017

1 reference